Serving hundreds of leading biopharmaceutical companies globally:

Generated: December 16, 2018

DrugPatentWatch Database Preview

RAXIBACUMAB Drug Profile

« Back to Dashboard

Summary for Tradename: RAXIBACUMAB

Patents:	7
Applicants:	1
BLAs:	1
Suppliers: see list	2

Pharmacology for RAXIBACUMAB

Mechanism of Action	Anthrax Protective Antigen-directed Antibody Interactions

US Patents for RAXIBACUMAB

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Human Genome Sciences Inc.	RAXIBACUMAB	raxibacumab	INJECTABLE; IV (INFUSION)	125349	001	2012-12-14	➤ Sign Up	LegoChem Biosciences, Inc. (Daejeon, KR)	➤ Sign Up	RX		search
Human Genome Sciences Inc.	RAXIBACUMAB	raxibacumab	INJECTABLE; IV (INFUSION)	125349	001	2012-12-14	➤ Sign Up	LegoChem Biosciences, Inc. (Daejeon, KR)	➤ Sign Up	RX		search
Human Genome Sciences Inc.	RAXIBACUMAB	raxibacumab	INJECTABLE; IV (INFUSION)	125349	001	2012-12-14	➤ Sign Up	CureVac AG (Tubingen, DE)	➤ Sign Up	RX		search
Human Genome Sciences Inc.	RAXIBACUMAB	raxibacumab	INJECTABLE; IV (INFUSION)	125349	001	2012-12-14	➤ Sign Up	SynChem, Inc. (Elk Grove Village, IL)	➤ Sign Up	RX		search
Human Genome Sciences Inc.	RAXIBACUMAB	raxibacumab	INJECTABLE; IV (INFUSION)	125349	001	2012-12-14	➤ Sign Up	Aegis Therapeutics, LLC (San Diego, CA)	➤ Sign Up	RX		search
Human Genome Sciences Inc.	RAXIBACUMAB	raxibacumab	INJECTABLE; IV (INFUSION)	125349	001	2012-12-14	➤ Sign Up	Aegis Therapeutics LLC (San Diego, CA)	➤ Sign Up	RX		search
Human Genome Sciences Inc.	RAXIBACUMAB	raxibacumab	INJECTABLE; IV (INFUSION)	125349	001	2012-12-14	➤ Sign Up	CureVac AG (Tubingen, DE)	➤ Sign Up	RX		search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patents for RAXIBACUMAB

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
European Patent Office	2814963	➤ Sign Up
India	5670DEN2014	➤ Sign Up
China	108570468	➤ Sign Up
Japan	2015508646	➤ Sign Up
China	104114705	➤ Sign Up
World Intellectual Property Organization (WIPO)	2010151707	➤ Sign Up
Japan	2018110588	➤ Sign Up
Country	Document Number	Estimated Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission

Teva

Citi

Cipla

Accenture

Express Scripts

Baxter

Chinese Patent Office

Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.